AU2001296637A1 - Gamma-glutamyl transpeptidase inhibitors - Google Patents

Gamma-glutamyl transpeptidase inhibitors

Info

Publication number
AU2001296637A1
AU2001296637A1 AU2001296637A AU9663701A AU2001296637A1 AU 2001296637 A1 AU2001296637 A1 AU 2001296637A1 AU 2001296637 A AU2001296637 A AU 2001296637A AU 9663701 A AU9663701 A AU 9663701A AU 2001296637 A1 AU2001296637 A1 AU 2001296637A1
Authority
AU
Australia
Prior art keywords
gamma
glutamyl transpeptidase
transpeptidase inhibitors
inhibitors
glutamyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2001296637A
Inventor
Scott A. Gabel
Robert E. London
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
National Institutes of Health NIH
Original Assignee
US Department of Health and Human Services
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by US Department of Health and Human Services filed Critical US Department of Health and Human Services
Publication of AU2001296637A1 publication Critical patent/AU2001296637A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F5/00—Compounds containing elements of Groups 3 or 13 of the Periodic Table
    • C07F5/02—Boron compounds
    • C07F5/027—Organoboranes and organoborohydrides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C229/00—Compounds containing amino and carboxyl groups bound to the same carbon skeleton
    • C07C229/02—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton
    • C07C229/04—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated
    • C07C229/22—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated the carbon skeleton being further substituted by oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/28—Phosphorus compounds with one or more P—C bonds
    • C07F9/38—Phosphonic acids [RP(=O)(OH)2]; Thiophosphonic acids ; [RP(=X1)(X2H)2(X1, X2 are each independently O, S or Se)]
    • C07F9/3804—Phosphonic acids [RP(=O)(OH)2]; Thiophosphonic acids ; [RP(=X1)(X2H)2(X1, X2 are each independently O, S or Se)] not used, see subgroups
    • C07F9/3808—Acyclic saturated acids which can have further substituents on alkyl

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AU2001296637A 2000-10-05 2001-10-04 Gamma-glutamyl transpeptidase inhibitors Abandoned AU2001296637A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US23832000P 2000-10-05 2000-10-05
US60238320 2000-10-05
PCT/US2001/031225 WO2002028869A1 (en) 2000-10-05 2001-10-04 Gamma-glutamyl transpeptidase inhibitors

Publications (1)

Publication Number Publication Date
AU2001296637A1 true AU2001296637A1 (en) 2002-04-15

Family

ID=22897390

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2001296637A Abandoned AU2001296637A1 (en) 2000-10-05 2001-10-04 Gamma-glutamyl transpeptidase inhibitors

Country Status (2)

Country Link
AU (1) AU2001296637A1 (en)
WO (1) WO2002028869A1 (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU1658401A (en) * 1999-11-19 2001-05-30 Topgene, Inc. Boron compounds and complexes as anti-inflammatory agents
WO2008137446A1 (en) * 2007-05-03 2008-11-13 Trustees Of Boston University Methods and compositions for the treatment of respiratory disease
IT201800010907A1 (en) 2018-12-10 2020-06-10 Stazione Zoologica Anton Dohrn 5-THIOISTIDINS AND METHYLATED DERIVATIVES (EGGS) AS GAMMAGLUTAMIL-TRANSPEPTIDASE (GGT) ACTIVITY INHIBITORS

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6310093B1 (en) * 1997-08-29 2001-10-30 Elan Pharmaceuticals, Inc. Method of preventing neuronal death

Also Published As

Publication number Publication date
WO2002028869A1 (en) 2002-04-11

Similar Documents

Publication Publication Date Title
AU2001258771A1 (en) -secretase inhibitors
AU2001237041A1 (en) Kinase inhibitors
AU2001234484A1 (en) Amide compounds for inhibiting protein kinases
AU2001244399A1 (en) Gamma-secretase inhibitors
SI1686119T1 (en) Pyrimidine-5-one derivatives as LDL-PLA2 inhibitors
AU2001296961A1 (en) 17-beta-hydroxysteroid dehydrogenase-ii inhibitors
AU2002211663A1 (en) Nf-$g(k)b inhibitors
AU2002220241A1 (en) Parb inhibitors
AU6007200A (en) Cysteine protease inhibitors
AU2001285750A1 (en) Urokinase inhibitors
AU2002230385A1 (en) Peptide deformylase inhibitors
AU5248800A (en) Fading inhibitors
AU2001247589A1 (en) Non-amidine containing protease inhibitors
AU2001294557A1 (en) Thrombin inhibitors
AU2001236052A1 (en) Urease inhibitors
AU2002211662A1 (en) Nf-kappab inhibitors
AU2001236623A1 (en) Hydantoin c-proteinase inhibitors
AU2001258841A1 (en) Heterocyclic compounds
AU3235100A (en) Prothease inhibitors
GB0030284D0 (en) Enzyme inhibitors
AU1588901A (en) Protease inhibitors
AU1474801A (en) Protease inhibitors
AU2001255408A1 (en) Tetrahydro-azepinone derivatives as thrombin inhibitors
AU4066900A (en) Protease inhibitors
AU1474701A (en) Protease inhibitors